spr_logo.png
SPRINT® PNS Demonstrates Robust Results in Addressing Chronic Shoulder Pain
August 06, 2024 09:00 ET | SPR Therapeutics, Inc.
A new real-world retrospective analysis of patients who received 60-day PNS for chronic shoulder pain has been published in Pain Management.
spr_logo.png
SPR® Therapeutics Recognized as a Top Workplace in Northeast Ohio for the Third Year in a Row
June 23, 2024 10:00 ET | SPR Therapeutics, Inc.
Medical Device Leader SPR Therapeutics again named a Top Workplace in Northeast Ohio
spr_logo.png
UPDATE - SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
May 14, 2024 18:33 ET | SPR Therapeutics, Inc.
Publication of study provides evidence of the impact of SPRINT PNS in relieving post-operative knee pain after total knee arthroplasty (TKA).
SPR Therapeutics LOGO 361 TM.jpg
SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
May 13, 2024 14:16 ET | SPR Therapeutics, Inc.
Publication of study provides evidence of the impact of SPRINT PNS in relieving post-operative knee pain after total knee arthroplasty (TKA).
SPR Therapeutics LOGO 361 TM.jpg
New SPRINT extensa XT™ System with Bimodal PNS™ Offers Synergistic Treatment of Pain
April 25, 2023 10:00 ET | SPR Therapeutics, Inc.
CLEVELAND, Ohio, April 25, 2023 (GLOBE NEWSWIRE) -- SPR® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or...
SPR Therapeutics LOGO 361 TM.jpg
SPR Therapeutics’ 14-Month Data from Multicenter Low Back Pain Trial Demonstrates Significant, Durable Impacts on Pain Intensity, Disability, and Pain Interference
March 16, 2023 08:00 ET | SPR Therapeutics, Inc.
CLEVELAND, March 16, 2023 (GLOBE NEWSWIRE) -- SPR Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients suffering from acute or...
SPR Therapeutics LOGO 361 TM.jpg
SPR Therapeutics to Present Clinical Trial and Real-World Findings at ASPN 2022
July 14, 2022 10:54 ET | SPR Therapeutics, Inc.
CLEVELAND, July 14, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics announced today that two presentations highlighting SPRINT® PNS in treating chronic pain will be featured at the American Society of...
SPR Therapeutics LOGO 361 TM.jpg
SPR Therapeutics Announces 10,000th SPRINT PNS Procedure for Patients Suffering from Life-altering Pain
May 12, 2022 09:00 ET | SPR Therapeutics, Inc.
CLEVELAND, May 12, 2022 (GLOBE NEWSWIRE) -- Cleveland based medical device company SPR Therapeutics today announced a key milestone with the 10,000th patient treated using the SPRINT® PNS System....
SPR Therapeutics LOGO 361 TM.jpg
Real-world Study of SPRINT 60-day Peripheral Nerve Stimulation (PNS) Corroborates Published Clinical Study Results
May 06, 2022 09:24 ET | SPR Therapeutics, Inc.
CLEVELAND, May 06, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics announced the publication of a study that evaluated the real-world impact of 60-day peripheral nerve stimulation (PNS) in the management...
SPR Therapeutics LOGO 361 TM.jpg
Prolonged Temporary Neurostimulation Treatment Period Offered by the SPRINT® PNS System May Optimize Pain Management Care Pathway While Reducing Healthcare Costs
March 15, 2022 10:31 ET | SPR Therapeutics, Inc.
CLEVELAND, March 15, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics announced publication of a study in the Journal of Pain Research demonstrating how a longer initial treatment period may better...